Structure-Based Design and Preclinical Characterization of Selective and Orally Bioavailable Factor

Lorthiois, Edwige; Roache, James; Barnes-Seeman, David; Altmann, Eva; Hassiepen, Ulrich; Turner, Gordon; Duvadie, Rohit; Hornak, Viktor; Karki, Rajeshri G.; Schiering, Nikolaus; Weihofen, Wilhelm A.; Perruccio, Francesca; Calhoun, Amy; Fazal, Tanzina; Dedic, Darija; Durand, Corinne; Dussauge, Solene; Fettis, Kamal; Tritsch, Fabien; Dentel, Celine; Druet, Adelaide; Liu, Donglei; Kirman, Louise; Lachal, Julie; Namoto, Kenji; Bevan, Douglas; Mo, Rose; Monnet, Gabriela; Muller, Lionel; Zessis, Richard; Huang, Xueming; Lindsley, Loren; Currie, Treeve; Chiu, Yu-Hsin; Fridrich, Cary; Delgado, Peter; Wang, Shuangxi; Hollis-Symynkywicz, Micah; Berghausen, Joerg; Williams, Eric; Liu, Hong; Liang, Guiqing; Kim, Hyungchul; Hoffmann, Peter; Hein, Andreas; Ramage, Paul; D?Arcy, Allan; Harlfinger, Stefanie; Renatus, Martin; Ruedisser, Simon; Feldman, David; Elliott, Jason; Sedrani, Richard; Maibaum, Juergen; Adams, Christopher M.

doi:10.1021/acs.jmedchem.0c00279

Structure-Based Design and Preclinical Characterization of Selective and Orally Bioavailable Factor

Journal Article · Mon Jun 01 04:00:00 EDT 2020 · J. Med. Chem.

DOI:https://doi.org/10.1021/acs.jmedchem.0c00279· OSTI ID:1834822

Lorthiois, Edwige; Roache, James; Barnes-Seeman, David; Altmann, Eva; Hassiepen, Ulrich; Turner, Gordon; Duvadie, Rohit; Hornak, Viktor; Karki, Rajeshri G.; Schiering, Nikolaus; Weihofen, Wilhelm A.; Perruccio, Francesca; Calhoun, Amy; Fazal, Tanzina; Dedic, Darija; Durand, Corinne; Dussauge, Solene; Fettis, Kamal; Tritsch, Fabien; Dentel, Celine more »

Research Organization:: Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)

Sponsoring Organization:: DOE - Office Of Science; INDUSTRY

OSTI ID:: 1834822

Journal Information:: J. Med. Chem., Journal Name: J. Med. Chem. Journal Issue: (15) Vol. 63

Country of Publication:: United States

Language:: ENGLISH

References (53)

Factor XIa inhibitors: A review of the patent literature Al-Horani, Rami A.; Desai, Umesh R. Expert Opinion on Therapeutic Patents, Vol. 26, Issue 3 https://doi.org/10.1517/13543776.2016.1154045	journal	February 2016
Potent, Orally Bioavailable, and Efficacious Macrocyclic Inhibitors of Factor XIa. Discovery of Pyridine-Based Macrocycles Possessing Phenylazole Carboxamide P1 Groups Corte, James R.; Pinto, Donald J. P.; Fang, Tianan Journal of Medicinal Chemistry, Vol. 63, Issue 2 https://doi.org/10.1021/acs.jmedchem.9b01768	journal	December 2019
Practical application of ligand efficiency metrics in lead optimisation Scott, James S.; Waring, Michael J. Bioorganic & Medicinal Chemistry, Vol. 26, Issue 11 https://doi.org/10.1016/j.bmc.2018.04.004	journal	July 2018
Discovery and Design of First Benzylamine-Based Ligands Binding to an Unlocked Conformation of the Complement Factor D Vulpetti, Anna; Ostermann, Nils; Randl, Stefan ACS Medicinal Chemistry Letters, Vol. 9, Issue 5 https://doi.org/10.1021/acsmedchemlett.8b00104	journal	April 2018
Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation: A Report From the Swedish Atrial Fibrillation Cohort Study Friberg, Leif; Rosenqvist, Mårten; Lip, Gregory Y. H. Circulation, Vol. 125, Issue 19 https://doi.org/10.1161/CIRCULATIONAHA.111.055079	journal	May 2012
Coagulation Assays Bates, Shannon M.; Weitz, Jeffrey I. Circulation, Vol. 112, Issue 4 https://doi.org/10.1161/CIRCULATIONAHA.104.478222	journal	July 2005
The thermodynamic basis for the use of lipophilic efficiency (LipE) in enthalpic optimizations Shultz, Michael D. Bioorganic & Medicinal Chemistry Letters, Vol. 23, Issue 21 https://doi.org/10.1016/j.bmcl.2013.08.030	journal	November 2013
Ligand efficiency indices as guideposts for drug discovery Abadzapatero, C.; Metz, J. Drug Discovery Today, Vol. 10, Issue 7 https://doi.org/10.1016/S1359-6446(05)03386-6	journal	April 2005
Exploiting Subsite S1 of Trypsin-Like Serine Proteases for Selectivity: Potent and Selective Inhibitors of Urokinase-Type Plasminogen Activator Mackman, Richard L.; Katz, Bradley A.; Breitenbucher, J. Guy Journal of Medicinal Chemistry, Vol. 44, Issue 23 https://doi.org/10.1021/jm010244+	journal	October 2001
Design of Small-Molecule Active-Site Inhibitors of the S1A Family Proteases as Procoagulant and Anticoagulant Drugs Fischer, Peter M. Journal of Medicinal Chemistry, Vol. 61, Issue 9 https://doi.org/10.1021/acs.jmedchem.7b00772	journal	October 2017
Discovery of the Novel Antithrombotic Agent 5-Chloro- N -({(5 S )-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): An Oral, Direct Factor Xa Inhibitor Roehrig, Susanne; Straub, Alexander; Pohlmann, Jens Journal of Medicinal Chemistry, Vol. 48, Issue 19 https://doi.org/10.1021/jm050101d	journal	September 2005
Structure-Based Library Design and Fragment Screening for the Identification of Reversible Complement Factor D Protease Inhibitors Vulpetti, Anna; Randl, Stefan; Rüdisser, Simon Journal of Medicinal Chemistry, Vol. 60, Issue 5 https://doi.org/10.1021/acs.jmedchem.6b01684	journal	February 2017
Complement factor D, a novel serine protease: Complement factor D Volanakis, John E.; Narayana, Sthanam V. L. Protein Science, Vol. 5, Issue 4 https://doi.org/10.1002/pro.5560050401	journal	April 1996
Discovery of Potent, Selective, Orally Active, Nonpeptide Inhibitors of Human Mast Cell Chymase Greco, Michael N.; Hawkins, Michael J.; Powell, Eugene T. Journal of Medicinal Chemistry, Vol. 50, Issue 8 https://doi.org/10.1021/jm0700619	journal	March 2007
Congenital Factor XI Deficiency: An Update Duga, Stefano; Salomon, Ophira Seminars in Thrombosis and Hemostasis, Vol. 39, Issue 06 https://doi.org/10.1055/s-0033-1353420	journal	August 2013
Factor XI as a target for antithrombotic therapy Bane, Charles E.; Gailani, David Drug Discovery Today, Vol. 19, Issue 9 https://doi.org/10.1016/j.drudis.2014.05.018	journal	September 2014
When to Start a Statin Is a Preference-Sensitive Decision Hayward, Rodney A. Circulation, Vol. 136, Issue 12 https://doi.org/10.1161/CIRCULATIONAHA.117.029808	journal	September 2017
Structure-based design, synthesis, and profiling of a β-tryptase inhibitor with a spiro-piperidineamide scaffold, benzylamine P1 group, and a substituted indole P4 group Liang, Guyan; Choi-Sledeski, Yong Mi; Poli, Gregory B. MedChemComm, Vol. 2, Issue 8 https://doi.org/10.1039/c1md00104c	journal	January 2011
The story of the discovery of heparin and warfarin Wardrop, Douglas; Keeling, David British Journal of Haematology, Vol. 141, Issue 6 https://doi.org/10.1111/j.1365-2141.2008.07119.x	journal	June 2008
Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF Bassand, Jean-Pierre; Accetta, Gabriele; Camm, Alan John European Heart Journal, Vol. 37, Issue 38 https://doi.org/10.1093/eurheartj/ehw233	journal	June 2016
Evaluation of the GastroPlus™ Advanced Compartmental and Transit (ACAT) Model in Early Discovery Gobeau, N.; Stringer, R.; De Buck, S. Pharmaceutical Research, Vol. 33, Issue 9 https://doi.org/10.1007/s11095-016-1951-z	journal	June 2016
Congenital prekallikrein deficiency Girolami, Antonio; Scarparo, Pamela; Candeo, Nicole Expert Review of Hematology, Vol. 3, Issue 6 https://doi.org/10.1586/ehm.10.69	journal	December 2010
Discovery of 1-(3‘-Aminobenzisoxazol-5‘-yl)-3-trifluoromethyl- N -[2-fluoro-4- [(2‘-dimethylaminomethyl)imidazol-1-yl]phenyl]-1 H -pyrazole-5-carboxyamide Hydrochloride (Razaxaban), a Highly Potent, Selective, and Orally Bioavailable Factor Xa Inhibitor Quan, Mimi L.; Lam, Patrick Y. S.; Han, Qi Journal of Medicinal Chemistry, Vol. 48, Issue 6 https://doi.org/10.1021/jm0497949	journal	March 2005
Structure-based design of inhibitors of coagulation factor XIa with novel P1 moieties Pinto, Donald J. P.; Smallheer, Joanne M.; Corte, James R. Bioorganic & Medicinal Chemistry Letters, Vol. 25, Issue 7 https://doi.org/10.1016/j.bmcl.2015.01.028	journal	April 2015
Oral Anticoagulant Therapy Ageno, Walter; Gallus, Alexander S.; Wittkowsky, Ann Chest, Vol. 141, Issue 2 https://doi.org/10.1378/chest.11-2292	journal	February 2012
Recent evolutionary divergence of plasma prekallikrein and factor XI Veloso, D.; Shilling, J.; Shine, J. Thrombosis Research, Vol. 43, Issue 2 https://doi.org/10.1016/0049-3848(86)90056-3	journal	July 1986
National Trends in Oral Anticoagulant Use in the United States, 2007 to 2011 Kirley, Kate; Qato, Dima M.; Kornfield, Rachel Circulation: Cardiovascular Quality and Outcomes, Vol. 5, Issue 5 https://doi.org/10.1161/CIRCOUTCOMES.112.967299	journal	September 2012
Discovery of 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro- 1 H -pyrazolo[3,4- c ]pyridine-3-carboxamide (Apixaban, BMS-562247), a Highly Potent, Selective, Efficacious, and Orally Bioavailable Inhibitor of Blood Coagulation Factor Xa Pinto, Donald J. P.; Orwat, Michael J.; Koch, Stephanie Journal of Medicinal Chemistry, Vol. 50, Issue 22 https://doi.org/10.1021/jm070245n	journal	November 2007
Factor XI and contact activation as targets for antithrombotic therapy Gailani, D.; Bane, C. E.; Gruber, A. Journal of Thrombosis and Haemostasis, Vol. 13, Issue 8 https://doi.org/10.1111/jth.13005	journal	June 2015
Discovery of a Parenteral Small Molecule Coagulation Factor XIa Inhibitor Clinical Candidate (BMS-962212) Pinto, Donald J. P.; Orwat, Michael J.; Smith, Leon M. Journal of Medicinal Chemistry, Vol. 60, Issue 23 https://doi.org/10.1021/acs.jmedchem.7b01171	journal	November 2017
Inhibition of Factor XI activity as a promising antithrombotic strategy Chen, Zhu; Seiffert, Dietmar; Hawes, Brian Drug Discovery Today, Vol. 19, Issue 9 https://doi.org/10.1016/j.drudis.2014.04.018	journal	September 2014
Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis Büller, Harry R.; Bethune, Claudette; Bhanot, Sanjay New England Journal of Medicine, Vol. 372, Issue 3 https://doi.org/10.1056/NEJMoa1405760	journal	January 2015
Interaction with the S1$beta;-pocket of urokinase: 8-heterocycle substituted and 6,8-disubstituted 2-naphthamidine urokinase inhibitors Wendt, M. Bioorganic & Medicinal Chemistry Letters, Vol. 14, Issue 12 https://doi.org/10.1016/S0960-894X(04)00530-X	journal	June 2004
The influence of drug-like concepts on decision-making in medicinal chemistry Leeson, Paul D.; Springthorpe, Brian Nature Reviews Drug Discovery, Vol. 6, Issue 11 https://doi.org/10.1038/nrd2445	journal	November 2007
P450-Mediated Metabolism of 1-[3-(Aminomethyl)phenyl]- N -[3-fluoro-2‘-(methylsulfonyl)- [1,1‘-biphenyl]-4-yl]-3-(trifluoromethyl)-1 H -pyrazole- 5-carboxamide (DPC 423) and Its Analogues to Aldoximes. Characterization of Glutathione Conjugates of Postulated Intermediates Derived from Aldoximes Mutlib, Abdul E.; Chen, Shiang-Yuan; Espina, Robert J. Chemical Research in Toxicology, Vol. 15, Issue 1 https://doi.org/10.1021/tx0101189	journal	December 2001
The role of molecular size in ligand efficiency Reynolds, Charles H.; Bembenek, Scott D.; Tounge, Brett A. Bioorganic & Medicinal Chemistry Letters, Vol. 17, Issue 15 https://doi.org/10.1016/j.bmcl.2007.05.038	journal	August 2007
An Analysis of the Binding Efficiencies of Drugs and Their Leads in Successful Drug Discovery Programs Perola, Emanuele Journal of Medicinal Chemistry, Vol. 53, Issue 7 https://doi.org/10.1021/jm100118x	journal	April 2010
Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis Ryckmans, Thomas; Edwards, Martin P.; Horne, Val A. Bioorganic & Medicinal Chemistry Letters, Vol. 19, Issue 15 https://doi.org/10.1016/j.bmcl.2009.05.062	journal	August 2009
Identification of orally bioavailable, non-amidine inhibitors of Urokinase Plasminogen Activator (uPA) West, Christopher W.; Adler, Marc; Arnaiz, Danny Bioorganic & Medicinal Chemistry Letters, Vol. 19, Issue 19 https://doi.org/10.1016/j.bmcl.2009.08.008	journal	October 2009
Scope of the Two-Step, One-Pot Palladium-Catalyzed Borylation/Suzuki Cross-Coupling Reaction Utilizing Bis-Boronic Acid Molander, Gary A.; Trice, Sarah L. J.; Kennedy, Steven M. The Journal of Organic Chemistry, Vol. 77, Issue 19 https://doi.org/10.1021/jo301642v	journal	September 2012
Ligand efficiency: a useful metric for lead selection Hopkins, Andrew L.; Groom, Colin R.; Alex, Alexander Drug Discovery Today, Vol. 9, Issue 10 https://doi.org/10.1016/S1359-6446(04)03069-7	journal	May 2004
MAA868, a novel FXI antibody with a unique binding mode, shows durable effects on markers of anticoagulation in humans Koch, Alexander W.; Schiering, Nikolaus; Melkko, Samu Blood, Vol. 133, Issue 13 https://doi.org/10.1182/blood-2018-10-880849	journal	March 2019
Structure-Based Design of Novel Potent Nonpeptide Thrombin Inhibitors Hauel, Norbert H.; Nar, Herbert; Priepke, Henning Journal of Medicinal Chemistry, Vol. 45, Issue 9 https://doi.org/10.1021/jm0109513	journal	April 2002
Contact system revisited: an interface between inflammation, coagulation, and innate immunity Long, A. T.; Kenne, E.; Jung, R. Journal of Thrombosis and Haemostasis, Vol. 14, Issue 3 https://doi.org/10.1111/jth.13235	journal	February 2016
Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation Yao, Xiaoxi; Abraham, Neena S.; Sangaralingham, Lindsey R. Journal of the American Heart Association, Vol. 5, Issue 6 https://doi.org/10.1161/JAHA.116.003725	journal	June 2016
The maximal affinity of ligands Kuntz, I. D.; Chen, K.; Sharp, K. A. Proceedings of the National Academy of Sciences, Vol. 96, Issue 18 https://doi.org/10.1073/pnas.96.18.9997	journal	August 1999
Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with vitamin K antagonists in patients with nonvalvular atrial fibrillation: a systematic literature review Briere, Jean-Baptiste; Bowrin, Kevin; Coleman, Craig Expert Review of Pharmacoeconomics & Outcomes Research, Vol. 19, Issue 1 https://doi.org/10.1080/14737167.2018.1518134	journal	September 2018
Design, Synthesis, and Preclinical Characterization of Selective Factor D Inhibitors Targeting the Alternative Complement Pathway Karki, Rajeshri G.; Powers, James; Mainolfi, Nello Journal of Medicinal Chemistry, Vol. 62, Issue 9 https://doi.org/10.1021/acs.jmedchem.9b00271	journal	April 2019
The discovery of fluoropyridine-based inhibitors of the Factor VIIa/TF complex Kohrt, Jeffrey T.; Filipski, Kevin J.; Cody, Wayne L. Bioorganic & Medicinal Chemistry Letters, Vol. 15, Issue 21 https://doi.org/10.1016/j.bmcl.2005.07.059	journal	November 2005
First-in-human study to assess the safety, pharmacokinetics and pharmacodynamics of BMS-962212, a direct, reversible, small molecule factor XIa inhibitor in non-Japanese and Japanese healthy subjects: First-in-human study of BMS-962212 a first-in-class small molecule factor XIa inhibitor Perera, Vidya; Luettgen, Joseph M.; Wang, Zhaoqing British Journal of Clinical Pharmacology, Vol. 84, Issue 5 https://doi.org/10.1111/bcp.13520	journal	March 2018
Factor XIa Inhibitors as New Anticoagulants Quan, Mimi L.; Pinto, Donald J. P.; Smallheer, Joanne M. Journal of Medicinal Chemistry, Vol. 61, Issue 17 https://doi.org/10.1021/acs.jmedchem.8b00173	journal	May 2018
Engineering inhibitors highly selective for the S1 sites of Ser190 trypsin-like serine protease drug targets Katz, Bradley A.; Sprengeler, Paul A.; Luong, Christine Chemistry & Biology, Vol. 8, Issue 11 https://doi.org/10.1016/S1074-5521(01)00084-9	journal	November 2001
Bioactivation of Benzylamine to Reactive Intermediates in Rodents: Formation of Glutathione, Glutamate, and Peptide Conjugates Mutlib, Abdul E.; Dickenson, Patricia; Chen, Shiang-Yuan Chemical Research in Toxicology, Vol. 15, Issue 9 https://doi.org/10.1021/tx020063q	journal	August 2002

Similar Records

Structure-Based Design of Potent, Selective, and Orally Bioavailable VPS34 Kinase Inhibitors

Journal Article · Fri Dec 31 23:00:00 EST 2021 · J. Med. Chem. · OSTI ID:1900949

Structure-Based Design of Active-Site-Directed, Highly Potent, Selective, and Orally Bioavailable Lo

Journal Article · Sat Oct 01 00:00:00 EDT 2022 · J. Med. Chem. · OSTI ID:1901192

Structure based design of macrocyclic factor XIa inhibitors: Discovery of cyclic P1 linker moieties with improved oral bioavailability

Journal Article · Fri Oct 25 00:00:00 EDT 2019 · Bioorg. Med. Chem. Lett. · OSTI ID:1572535

Structure-Based Design and Preclinical Characterization of Selective and Orally Bioavailable Factor

Citation Formats

References (53)

Similar Records

Related Subjects